|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 409/10 | (2006.01) |
| A61K 31/381 | (2006.01) | ||
| A61P 5/00 | (2006.01) |
| (11) | Number of the document | 3394051 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16819899.2 |
| Date of filing the European patent application | 2016-12-20 | |
| (97) | Date of publication of the European application | 2018-10-31 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-22 |
| (46) | Date of publication of the claims translation | 2020-08-10 |
| (86) | Number | PCT/EP2016/081861 |
| Date | 2016-12-20 |
| (87) | Number | WO 2017/108752 |
| Date | 2017-06-29 |
| (30) | Number | Date | Country code |
| 15201459 | 2015-12-21 | EP | |
| 16172070 | 2016-05-31 | EP |
| (72) |
DE KEYSER, Ruben, BE
LAPS, Stijn, BE
RAMMELOO, Thomas Joachim Landewald, BE
WEERTS, Koen Johan Herman, BE
|
| (73) |
Janssen Pharmaceutica N.V.,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kristalizacijos procedūra, skirta kanagliflozino hemihidrato kristalų gavimui |
| CRYSTALLIZATION PROCEDURE FOR OBTAINING CANAGLIFLOZIN HEMIHYDRATE CRYSTALS |
| Payment date | Validity (years) | Amount | |
| 2022-12-15 | 7 | 162.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2036-12-20 |